Other medicines, foods and herbal products can change how Prazosin works. Everything on this page comes from Prazosin's own FDA-approved label — the same source as the main guide.
Grouped the way the label groups them. Each name links to that medicine's NepalDoc guide; where the label names a class instead of a medicine, the label's words are quoted.
Prazosin hydrochloride has been administered without any adverse drug interaction in limited clinical experience to date with the following: cardiac glycosides– digitalis and digoxin; hypoglycemics–insulin, chlorpropamide, phenformin, tolazamide, and tolbutamide; tranquilizers and sedatives–chlordiazepoxide, diazepam, and phenobarbital; antigout– allopurinol, colchicine, and probenecid; antiarrhythmics–procainamide, propranolol , and quinidine; and analgesics, antipyretics and anti-inflammatories– propoxyphene, aspirin, indomethacin, and phenylbutazone.
Prazosin's label names 11 medicines that NepalDoc also covers.
These medicines named in Prazosin's label have interaction pages of their own:
Prazosin hydrochloride has been administered without any adverse drug interaction in limited clinical experience to date with the following: cardiac glycosides– digitalis and digoxin; hypoglycemics–insulin, chlorpropamide, phenformin, tolazamide, and tolbutamide; tranquilizers and sedatives–chlordiazepoxide, diazepam, and phenobarbital; antigout– allopurinol, colchicine, and probenecid; antiarrhythmics–procainamide, propranolol , and quinidine; and analgesics, antipyretics and anti-inflammatories– propoxyphene, aspirin, indomethacin, and phenylbutazone. Addition of a diuretic or other antihypertensive agent to prazosin hydrochloride has been shown to cause an additive hypotensive effect. This effect can be minimized by reducing the prazosin hydrochloride dose to 1 mg to 2 mg three times a day, by introducing additional antihypertensive drugs cautiously, and then by retitrating prazosin hydrochloride based on clinical response. Concomitant administration of prazosin hydrochloride with a phosphodiesterase-5 (PDE-5) inhibitor can result in additive blood pressure lowering effects and symptomatic hypotension .
Prazosin guide · All interaction pages · Medicines A–Z
This page summarises Prazosin's FDA-approved label for information — it is not medical advice. Always tell your doctor or pharmacist about every medicine, supplement and herbal product you take.
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. NLEM listing does not guarantee that a medicine is in stock at any pharmacy.
Every NepalDoc section, one tap away.
Find doctors by specialty across Nepal.